This is a 53 year old female who:
is being seen for a chief complaint of chronic low back pain involving the spine
Context: having
chronic back pain
They are constant
Quality: aching
Severity is 7 out of 10 currently
Is being seen for a chief complaint of follow up low back pain involving the spine
Symptoms are
aggravated by all movement
They are constant
Quality: aching and sharp
Severity is 6 out of 10
currently
Since the last visit, the status of the problem is unchanged
Secondary Complaints include: The patient complains of thoracic spine pain
The symptoms are 7 out of, Date Taken By B.P
Pulse Resp
O2 Sat
Temp
Ht
Wt
BMI BSA
07.2026 - 01.2024
Patient presents today for follow-up regarding chronic axial mid back and lumbar spine pain
Patient recently trialed on duloxetine, side effect of persistent nausea minimal relief to 90 with medication
Patient request continued on this medication
Patient is also previously trialed gabapentin and pregabalin
discontinued those due to significant side effects
Patient did have to reschedule her confirmatory bilateral T9/T10, T10/T11 thoracic medial branch block
#2, this will be completed and was evaluated at her next office visit
Patient gets significant pain relief from this we will consider radiofrequency ablation at the same level
Patient currently takes hydrocodone 7.5 mg / 325 mg every 8 hours, as needed
Approximately 70 to 80% pain relief when taking hydrocodone denies significant side effects
UDS and PDMP are appropriate
Patient also has been contacted by Zynex, her e-stim for her back pain should be shipping soon
Today I have ordered a repeat thoracic and lumbar spine MRI due to patient's severe persistent spine
pain.
Sex
Ocala, FL
01.2005 - 12 0
Quality 134 (Screening for Clinical Depression and Follow-Up Plan): The patient was screened for depression and the screen was
negative and no follow up required
Additional Notes: PHQ2 depression screening administered, negative result found
Right LE Pulses: normal posterior tibialis and dorsal
pedis pulses, brisk capillary refill, no edema
Left LE Pulses: normal posterior tibialis and dorsal
pedis pulses, brisk capillary refill, no edema
Data Reviewed:Review of the result(s) of each unique test (Toxicology Review (no))
Impression/Plan:
Spondylosis, Lumbar
Problem Addressed: Stable chronic illness
Spondylosis without myelopathy or radiculopathy, lumbar region (M47.816)
Thoracic Spine Pain
Problem Addressed: Stable chronic illness
Pain in thoracic spine (M54.6)
Plan: Prescription
Hydrocodone 7.5 mg-acetaminophen 325 mg tablet PO
Sig: One po Q 8 hrs as needed for non acute pain
Quantity: 90 Tablet Earliest fill date: September 28, 2024
baclofen 10 mg tablet PO
Sig: One tablet q 12 hours as needed for muscle spasms
Quantity: 60 Tablet Earliest fill date: September 20, 2024
Valium 5 mg tablet PO
Sig: Bring tablet to procedure will be instructed on use
Quantity: 1 Tablet Earliest fill date: September 20, 2024
Long term (current) use of opiate analgesic
Problem Addressed: Stable chronic illness
Long term (current) use of opiate analgesic (Z79.891)
Plan: Morphine Milligram Equivalent
All conversion factors yield MILLIGRAM morphine equivalent
Hydrocodone (mg/day): 21
Morphine Milligram Equivalent per day: 21.00
Plan: State Opioid Prescribing Database Reviewed
The state database has been accessed and reviewed prior to prescribing a Class II and/or Class III controlled substance
Plan: Counseling - Medication Monitoring
Opioid Counseling
Medication Counseling Other : Risks associated with long term use of opioids: Given the patients diagnosis and persistent chronic
pain
Treatment with opioid analgesic medication will likely be required for long term use
At this visit I discussed the possible
development of adverse-affects from the long-term use of opioids including: the development of physical tolerance to the
medication, development of hyperalgesia and/or development of physical addiction
I have further explained to the patient that any
one adverse-affect may require either opioid rotation, tapering or discontinuation
Safe use of Controlled Substance medication: The patient was instructed to take their controlled substance medication only as
directed
The patient was also advised not to consume any alcohol or illicit substances throughout the course of treatment with the
controlled substance(s)
The patient was asked to review the type of medication and instructions for administration at time of
prescription pick-up from the pharmacy to confirm correct medication and instructions have been given
The patient was also
instructed on the potential side-affects that may occur with use of controlled substance(s) as well as signs of over medication
Ocala, 34471
patient were to develop any slurred speech, dizziness, confusion, excessive drowsiness, trouble breathing, skin pallor, or difficulty
waking from sleep he/she was advised to discontinue use of the controlled substance medication and to call the office or visit the
emergency room
Safe storage of Controlled Substance medication: The patient was instructed that all controlled substance medications should be
stored in their original bottles inside a locked cabinet, lockbox or a location where others cannot easily access them.
09.2020
2435
Hicks, Kathy 128/84
SIT69.0 in 250.0
lbs9 2.3
FiO2
Patient Reported
Care timeline
Management history log
Summary:
patient is here for follow-up visit, patient has been seen by Dr
Shetty
Status post bilateral L4-L5
transforaminal ESI on February 20, 2024 with Dr
Wei, greater than 80% relief for radiating pain to the
right side anterior rib cage
Her main complaint is of right side of thoracic spine MRI her main complaint is right side of thoracic spine
T9-T12, she has tried ice, heat, NSAIDs, she is currently on physical therapy
She is having radicular pain
to right cage and right flank from right side of thoracic spine
Her pain level is 8 out of 10 and pain is
intensifying
She is not able to stand or sit for longer than 5 minutes
28/2024
Patient presents today for follow-up visit regarding her chronic axial mid back pain and her chronic low
back pain
Patient longstanding patient with Dr
Shetty manage for her low back pain
She is status post several lumbar L4/L5, L5/S1 transforaminal epidurals with variations of those over the
years with Dr
Shetty, patient reports transient relief with these injections with 1 injection lasting
approximately 1 week
Patient's status post bilateral T9/T10, T10/T11 thoracic medial branch block #1 4/30/2024 patient reports
significant swelling at the injection site after the procedure but reports 80% pain relief for duration of
anesthetic
We will proceed with the additional trial injection if that is successful we will plan for RFA at these levels
Patient currently taking hydrocodone 7.5-325 milligrams, every 8 hours, for her chronic low back and mid
back pain
Patient reports approximately 80% pain relief for the duration of the medication which allows
her to increase her mobility and complete her ADLs
She has previous taken gabapentin, pregabalin, in the past, discontinued due to side effects
UDT consistent
PDMP reviewed and consistent
Patient has completed several rounds of physical therapy for her mid back pain, patient states that the
physical therapy itself was marginal in benefit but the commercial grade e-stim machine that was used on
her mid back did provide great relief for her chronic thoracic spine pain
Today I have ordered a Zynex
estim device to be used for patient's chronic mid back pain in addition to the interventional procedures
Visit Note - September 20, 2024
BENZ, AMY
MRN:
FPA561035
Phone:
(352) 414-9837
DOB:
08.2026
24
S/p Bilateral Levels: T9-T10 and T10-T11 MBB #2, 8/6/24, reporting >80% pain relief x 24 hrs
Discussed to Schedule RFA T-spine with Dr
Wei
Completed lumbar and thoracic spine
Discussed findings with patient and plans for future intervention
post MBB/RFA T-spine procedure
Previous management:
previous therapies:, events: Gabapentin, pregabalin–stopped both due to side effects, Topamax–discontinued due to
severe side effects
NSAIDs: Previous treatment with meloxicam, meloxicam, Voltaren, Aleve, naproxen–patient reports
feeding therapy with these medications
Muscle relaxants: Flexeril, tizanidine, baclofen–fleeting response with these medications
Other:
Plan
Meds:
Visit Note - September 20, 2024
BENZ, AMY
MRN:
FPA561035
Phone:
(352) 414-9837
DOB:
Skills
Mcg/actuation Nasal -
Spray,suspension
Amlodipine 5 mg Oral - tablet
Celecoxib 200 mg Oral - capsule
Cyclobenzaprine 10 mg Oral -
Tablet
Duloxetine 20 mg Oral - Dose: 1
Capsule capsule,delayed
Release (ec) Frequency: Once
A day
Hydrocodone-acetaminophen
75-325 mg Oral - tablet
Hydroxyzine HCl 10 mg Oral -
Losartan 25 mg Oral - tablet
Meloxicam 15 mg Oral - tablet
Rosuvastatin 10 mg Oral - tablet
Tizanidine 2 mg Oral - tablet
Medical History
Reviewed August 26, 2024
Chronic pain
Fatigue
Gastroesophageal reflux
Disease
H/O: depression
H/O: varicose veins
Headache: Migraines
Hernia: hiatal
History of urinary tract infection
Hypercholesterolemia
Insomnia
Obesity
Sleep apnea
Other: High Blood Pressure
Urinary Incontinence
Interventional Pain
Musculoskeletal
History
Chronic low back pain
Fracture of ankle
H/O: arthritis
Neuropathy
Sciatica
Spinal stenosis of lumbar region
Family History
Diabetes
Hypertension
Osteoarthritis
Osteoporosis
Scoliosis
Chief Complaints:
Chronic Low Back Pain1
Follow Up Low Back Pain2
Accomplishments
T spine and L spine MRI
Procedure: Bilateral T9/T10, T10/T11 thoracic medial branch block #2 with Dr
Wei
If successful we will consider RFA at these levels
HEP: yes lumbar
RTC: 4 weeks
Findings:
General Appearance
Appearance: overweight, well developed, and well groomed
Orientation: Alert and oriented to person, place, time
Mood: mood and affect well-adjusted, pleasant and cooperative, appropriate for clinical and encounter
circumstances
T-spine
T-Spine ROM: Moderate to severe tenderness midline and Right > Left PV area of the mid thoracic spine
T-Spine Inspection: kyphoscoliosis, left paraspinal musculature tender to palpation, right paraspinal
musculature tender to palpation, and midline tenderness
TL-Spine and Hip
Gait: mildly antalgic
Upper Trunk Skin Inspection: skin intact, no rashes or lesions
Lower Trunk Skin Inspection: skin intact, no rashes or lesions
T-Spine Inspection: no paraspinal musculature tenderness and no scoliosis
L-Spine Inspection: left and right paraspinal musculature tender to palpation
Posture: lumbar hypolordosis: mild
Inspection:
Right Hip: no trochanteric tenderness
Inspection:
Left Hip: no trochanteric tenderness
L-Spine Stability: No bony step-off, no gross deformity, normal sagittal and coronal alignment
Thoracolumbar Spine Special: FABER test: negative on the left, FABER test: negative on the right
Facet Loading test: positive to the left, Facet Loading test: positive to the right, Facet Loading test:
positive to extension, Right SLR ipsilateral pain: negative, Left SLR ipsilateral pain: negative, and
Waddell's test: negative
Special: Special:
Visit Note - September 20, 2024
BENZ, AMY
MRN:
FPA561035
Phone:
(352) 414-9837, REASON > 72 HOUR RX GIVEN: Based on the patient’s chronic non-malignant pain, a prescription for greater than a 72-hour
supply of opioid analgesic medication is being prescribed today
The patient will require chronic long-term treatment with an opioid
analgesic to facilitate a reduction in the patient’s pain level as well as to maintain adequate physical function
PDMP reviewed at
this visit
At this visit we discussed and reviewed the non-opioid and non-narcotic alternatives including but not limited to physical therapy,
interventional pain procedures, and NSAIDS, if appropriate
The patient was provided with the information on Nonopioid Alternative
for the Treatment of Pain Pamphlet
Plan: Toxicology Review
Specimen Type: Urine
The following confirmation positive results were found: Hydrocodone and Norhydrocodone
Patient Specific Counseling: REV OF UDT 7/24/2024 hydrocodne and metabolites AND PDMP SHOWS COMPLIANCE
Patient Specific Counseling: -
High Risk Medication Monitoring Narcotics
Problem Addressed: No MDM
Long term (current) use of opiate analgesic (Z79.891)
Associated diagnosis: Encounter for therapeutic drug level monitoring (No MDM)
Plan: Toxicology Review
The state database has been accessed and reviewed prior to prescribing a Class II and/or Class III controlled substance
Urine drug screening is being ordered today to assess compliance with prescribed medications and identify common prescribed
and non-prescribed substances that can impact medical efficacy and patient safety
Based on the reason(s) indicated in the
completed scanned in lab requisition form, a Definitive Test will also be ordered
Date of Toxicology Testing: 07/26/2024
Specimen Type: Urine
Patient Specific Counseling: -
The following POC positive results were found: Opiates/Morphine
The following POC negative results were found: Amphetamines, Cocaine, Marijuana, and Methamphetamine
The following POC normal results were found: Bleach, Creatinine, Nitrate, pH, and Specific Gravity
MIPS
MIPS
Plan: MIPS Quality
Quality 317 (Preventative Care and Screening: Screening for High Blood Pressure and Follow-up Documented): Elevated or
hypertensive blood pressure reading documented, and the indicated follow-up is documented
Additional Notes: The patient is referred to their PCP and educated regarding hypertension
MIPS
Plan: MIPS Quality.
Interests
DOB:
, 05/19/1971
Sex:
Female,
Driving status:
, Drives in the Daytime
Drives at Night